van der Waal I
Department of Oral & Maxillofacial Surgery/Oral Pathology, Free University Hospital/ACTA, Amsterdam, The Netherlands.
FDI World. 1995 Mar-Apr;4(2):6-9.
Leukoplakia is the most common premalignant lesion of the oral mucosa. The term should be used only for white lesions that cannot be characterised as any other definable lesion. The chance of malignant transformation can to some extent be predicted on the basis of the clinical appearance, the oral subsite, and the histopathological findings in the biopsy. The management of patients with oral leukoplakia is primarily directed towards elimination of possible causative factors. If the lesion persists, treatment is recommended in most cases. Of the various available treatment modalities no one is superior to the others. Both treated and untreated patients should be scheduled for long term follow-up, probably life long, with 6-12 month intervals in order to he able to detect possible recurrences in an early stage. Erythroplakia is less common than leukoplakia, but carries a considerably higher risk of malignant transformation. Therefore, erythroplakias should always be removed and subsequently, followed up.
口腔白斑是口腔黏膜最常见的癌前病变。该术语仅用于不能被归类为任何其他可明确病变的白色损害。恶性转化的可能性在一定程度上可根据临床表现、口腔亚部位以及活检的组织病理学结果来预测。口腔白斑患者的治疗主要针对消除可能的致病因素。如果病变持续存在,大多数情况下建议进行治疗。在各种可用的治疗方式中,没有一种优于其他方式。接受治疗和未接受治疗的患者都应安排长期随访,可能是终身随访,间隔6 - 12个月,以便能够在早期检测到可能的复发。口腔红斑比口腔白斑少见,但恶性转化风险要高得多。因此,红斑应始终予以切除并随后进行随访。